Cargando…
Breastfeeding in women with rheumatic diseases
OBJECTIVE: Many rheumatologists and women with rheumatic disease worry that the disease or treatment will prevent breast feeding. International guidelines establish, however, that most antirheumatic medications are compatible with breast feeding. We sought to identify the frequency and predictors of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039217/ https://www.ncbi.nlm.nih.gov/pubmed/33832977 http://dx.doi.org/10.1136/lupus-2021-000491 |
_version_ | 1783677542322929664 |
---|---|
author | Ikram, Naira Eudy, Amanda Clowse, Megan E B |
author_facet | Ikram, Naira Eudy, Amanda Clowse, Megan E B |
author_sort | Ikram, Naira |
collection | PubMed |
description | OBJECTIVE: Many rheumatologists and women with rheumatic disease worry that the disease or treatment will prevent breast feeding. International guidelines establish, however, that most antirheumatic medications are compatible with breast feeding. We sought to identify the frequency and predictors of desire to and actually breast feeding in women with rheumatic diseases. METHODS: Pregnant women with rheumatic disease were enrolled prospectively. Demographics and breastfeeding intention were collected at study entry, while actual breastfeeding decision was recorded postpartum. Maternal diagnosis, demographics and medication use was collected throughout the study. Predictors of breast feeding and intention were identified using stepwise logistic regression. RESULTS: A total of 265 pregnancies were included in the study, 88 with SLE, 33 with undifferentiated connective tissue disease, 100 with arthritis and 44 with other rare rheumatic diagnoses. Of these, 79% intended to breastfeed, 84% of women ever breast fed and 65% were still breast feeding at an average of 7.6 weeks postpartum. Medication concern was the most commonly cited reason not to breastfeed though only 5% of women were taking or planning to start a non-lactation compatible medication at their postpartum visit. In multivariate analysis, women with a college degree were more likely and women with SLE were less likely to intend to breastfeed. Actual breast feeding was most strongly predicted by the woman’s intention to breastfeed, but also increased with maternal age, decreased if the baby was born preterm and decreased the further the postpartum appointment occurred from delivery. CONCLUSION: This study demonstrates that the majority of women with rheumatic disease want to and can breastfeed successfully. Additionally, very few women required a medication that was not compatible with breast feeding to control their rheumatic disease in the postpartum period. Despite this, an important minority of patients did not continue breast feeding due to their personal concerns about the risks of antirheumatic medications to their infant. |
format | Online Article Text |
id | pubmed-8039217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-80392172021-04-26 Breastfeeding in women with rheumatic diseases Ikram, Naira Eudy, Amanda Clowse, Megan E B Lupus Sci Med Reproductive health and APS OBJECTIVE: Many rheumatologists and women with rheumatic disease worry that the disease or treatment will prevent breast feeding. International guidelines establish, however, that most antirheumatic medications are compatible with breast feeding. We sought to identify the frequency and predictors of desire to and actually breast feeding in women with rheumatic diseases. METHODS: Pregnant women with rheumatic disease were enrolled prospectively. Demographics and breastfeeding intention were collected at study entry, while actual breastfeeding decision was recorded postpartum. Maternal diagnosis, demographics and medication use was collected throughout the study. Predictors of breast feeding and intention were identified using stepwise logistic regression. RESULTS: A total of 265 pregnancies were included in the study, 88 with SLE, 33 with undifferentiated connective tissue disease, 100 with arthritis and 44 with other rare rheumatic diagnoses. Of these, 79% intended to breastfeed, 84% of women ever breast fed and 65% were still breast feeding at an average of 7.6 weeks postpartum. Medication concern was the most commonly cited reason not to breastfeed though only 5% of women were taking or planning to start a non-lactation compatible medication at their postpartum visit. In multivariate analysis, women with a college degree were more likely and women with SLE were less likely to intend to breastfeed. Actual breast feeding was most strongly predicted by the woman’s intention to breastfeed, but also increased with maternal age, decreased if the baby was born preterm and decreased the further the postpartum appointment occurred from delivery. CONCLUSION: This study demonstrates that the majority of women with rheumatic disease want to and can breastfeed successfully. Additionally, very few women required a medication that was not compatible with breast feeding to control their rheumatic disease in the postpartum period. Despite this, an important minority of patients did not continue breast feeding due to their personal concerns about the risks of antirheumatic medications to their infant. BMJ Publishing Group 2021-04-08 /pmc/articles/PMC8039217/ /pubmed/33832977 http://dx.doi.org/10.1136/lupus-2021-000491 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Reproductive health and APS Ikram, Naira Eudy, Amanda Clowse, Megan E B Breastfeeding in women with rheumatic diseases |
title | Breastfeeding in women with rheumatic diseases |
title_full | Breastfeeding in women with rheumatic diseases |
title_fullStr | Breastfeeding in women with rheumatic diseases |
title_full_unstemmed | Breastfeeding in women with rheumatic diseases |
title_short | Breastfeeding in women with rheumatic diseases |
title_sort | breastfeeding in women with rheumatic diseases |
topic | Reproductive health and APS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039217/ https://www.ncbi.nlm.nih.gov/pubmed/33832977 http://dx.doi.org/10.1136/lupus-2021-000491 |
work_keys_str_mv | AT ikramnaira breastfeedinginwomenwithrheumaticdiseases AT eudyamanda breastfeedinginwomenwithrheumaticdiseases AT clowsemeganeb breastfeedinginwomenwithrheumaticdiseases |